Literature DB >> 29956759

Embelin inhibits abdominal aortic aneurysm through decreasing IL‑6‑induced STAT3 and NF‑κB inactivation.

Qiang Liu1, Qingshan Wang2, Haibin Li1.   

Abstract

The aim of the present study was to investigate the effect of embelin on abdominal aortic aneurysm (AAA). AAA model mice were induced by chronic infusion of 1,000 ng/kg/min Angiotensin II. AAA model mice were treated with 25, 50 or 100 mg/kg embelin for 28 days. Embelin inhibited tumor necrosis factor‑α, interleukin (IL)‑1β, IL‑6, IL‑18 and malondialdehyde (MDA) level activities, increased superoxide dismutase, glutathione (GSH) and GSH peroxidase level activities and inhibited MDA level activities in AAA mice Embelin suppressed the secretion of matrix metalloproteinase‑9 protein expression, monocyte chemoattractant protein‑2 activity and epithelial neutrophil‑activating peptide expression levels in AAA mice. Embelin suppressed phosphorylated‑signal transducer and activator of transcription (STAT) 3, phosphorylated‑p38 mitogen‑activated protein kinase and nuclear factor (NF)‑κB protein expression in AAA mice. These findings indicate that embelin inhibits AAA through decreasing IL‑6‑induced STAT3, and NF‑κB inactivation.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29956759     DOI: 10.3892/mmr.2018.9221

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  4 in total

1.  A novel STAT3 inhibitor attenuates angiotensin II-induced abdominal aortic aneurysm progression in mice through modulating vascular inflammation and autophagy.

Authors:  Qi-Ying Wu; Zhao Cheng; Yang-Zhao Zhou; Yuan Zhao; Jian-Ming Li; Xin-Min Zhou; Hong-Ling Peng; Guang-Sheng Zhang; Xiao-Bo Liao; Xian-Ming Fu
Journal:  Cell Death Dis       Date:  2020-02-18       Impact factor: 8.469

2.  Integrated analysis and the identification of a circRNA-miRNA-mRNA network in the progression of abdominal aortic aneurysm.

Authors:  Ke Si; Da Lu; Jianbo Tian
Journal:  PeerJ       Date:  2021-12-24       Impact factor: 2.984

Review 3.  Development of pharmacotherapies for abdominal aortic aneurysms.

Authors:  Lauren M Weaver; Charles D Loftin; Chang-Guo Zhan
Journal:  Biomed Pharmacother       Date:  2022-06-30       Impact factor: 7.419

4.  The Potential Role of hsa_circ_0005505 in the Rupture of Human Intracranial Aneurysm.

Authors:  Xin Chen; Shuzhe Yang; Junhua Yang; Qingyuan Liu; Maogui Li; Jun Wu; Hao Wang; Shuo Wang
Journal:  Front Mol Biosci       Date:  2021-07-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.